5 Results for "

Cdk2 Inhibitor III

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Cdk2 Inhibitor III" in MCE Product Catalog:

  • Targets Recommended:
9
9 Cited Publications
Cat. No.: HY-15339
CAS No.: 199986-75-9
Purity:  99.90%
Synonyms: Cdk2 Inhibitor III
Target:  

CDK

Research Areas:  

Cancer

CVT-313 (Cdk2 Inhibitor III) is a potent, selective, reversible, and ATP-competitive inhibitor of CDK2 with IC50 of 0.5 μM. CVT-313 inhibits CDC5L phosphorylation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-117393
CAS No.: 137592-43-9
Purity:  98.95%
Research Areas:  

Cancer

Bisindolylmaleimide III is a protein kinase C (PKC) inhibitor with IC50 values of 0.26, 5.7, and 6 μM against PKCα, PKCδ, and PKCμ, respectively. Bisindolylmaleimide III also exhibits inhibitory activity against other off-targets, with IC50 values of 0.17, 1, and 2 μM against SLK, adenosine kinase (AK), and CDK2, respectively; its Ki for NQO2 is 16.5 μM. Bisindolylmaleimide III selectively binds to activated Rsk1 following EGF stimulation, and serves as a tool for detecting the activation status of intracellular Rsk1 and PKCα, as well as for functional analysis of SLK. Bisindolylmaleimide III can be used in studies of signal transduction and colorectal cancer .
loading...
    loading...
Cat. No.: HY-112462
CAS No.: 443798-55-8
Purity:  99.69%
Target:  

CDK

Research Areas:  

Cancer

Cdk1/2 Inhibitor III (compound 3n) is a highly potent and selective Cdk1/cyclin B and Cdk2/cyclin A inhibitor of with IC50s of 0.6 nM and 0.5 nM, respectively. Cdk1/2 Inhibitor III shows selectivity over VEGF-R2 (IC50 of 32 nM), GSK-3β (IC50 of 140 nM), and a other kinases. Cdk1/2 Inhibitor III inhibits in cell proliferation with IC50s of 20 nM, 35 nM and 92 nM for HCT-116, HeLa, and A375 cells, respectively .
loading...
    loading...
Cat. No.: HY-163357
CAS No.: 3083904-06-4
Target:  

CDK MDM-2/p53

Research Areas:  

Cancer

CDK2/MDM2-IN-1 (III-13) is a dual inhibitor of CDK2/MDM2 with an IC50 value of 2.60 nM for CDK2. CDK2/MDM2-IN-1 has antitumor activity .
loading...
    loading...
Cat. No.: HY-112454
CAS No.: 683775-59-9
Research Areas:  

Cancer

Bisindolylmaleimide III hydrochloride is a protein kinase C (PKC) inhibitor with IC50 values of 0.26, 5.7, and 6 μM against PKCα, PKCδ, and PKCμ, respectively. Bisindolylmaleimide III hydrochloride also exhibits inhibitory activity against other off-targets, with IC50 values of 0.17, 1, and 2 μM against SLK, adenosine kinase (AK), and CDK2, respectively; its Ki for NQO2 is 16.5 μM. Bisindolylmaleimide III hydrochloride selectively binds to activated Rsk1 following EGF stimulation, and serves as a tool for detecting the activation status of intracellular Rsk1 and PKCα, as well as for functional analysis of SLK. Bisindolylmaleimide III hydrochloride can be used in studies of signal transduction and colorectal cancer .
loading...
    loading...